Evelo Biosciences Inc (EVLO) PT Lowered to $14 at Jefferies, Keeps 'Buy' Following EDP1815 Ph2 Psoriasis Data
Tweet Send to a Friend
Jefferies analyst Chris Howerton lowered the price target on Evelo Biosciences Inc (NASDAQ: EVLO) to $14.00 (from $18.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
